BIOCHEMICAL  ||| S:0 E:12 ||| NNP
EFFECTS  ||| S:12 E:20 ||| NNP
OF  ||| S:20 E:23 ||| IN
ESTROGENS  ||| S:23 E:33 ||| NNP
IN  ||| S:33 E:36 ||| IN
NON-REPRODUCTIVE  ||| S:36 E:53 ||| NNP
ORGANS  ||| S:53 E:60 ||| NNP
Biochemical  ||| S:60 E:72 ||| NNP
processes  ||| S:72 E:82 ||| VBZ
initiated  ||| S:82 E:92 ||| VBN
by  ||| S:92 E:95 ||| IN
estrogenic  ||| S:95 E:106 ||| JJ
hormones  ||| S:106 E:115 ||| NNS
in  ||| S:115 E:118 ||| IN
the  ||| S:118 E:122 ||| DT
organs  ||| S:122 E:129 ||| NNS
which  ||| S:129 E:135 ||| WDT
are  ||| S:135 E:139 ||| VBP
not  ||| S:139 E:143 ||| RB
directly  ||| S:143 E:152 ||| RB
related  ||| S:152 E:160 ||| VBN
to  ||| S:160 E:163 ||| TO
reproduction  ||| S:163 E:176 ||| NNS
were  ||| S:176 E:181 ||| VBD
described  ||| S:181 E:191 ||| VBN
in  ||| S:191 E:194 ||| IN
the  ||| S:194 E:198 ||| DT
survey  ||| S:198 E:205 ||| NN
on  ||| S:205 E:208 ||| IN
the  ||| S:208 E:212 ||| DT
basis  ||| S:212 E:218 ||| NN
of  ||| S:218 E:221 ||| IN
literature  ||| S:221 E:232 ||| NN
and  ||| S:232 E:236 ||| CC
the  ||| S:236 E:240 ||| DT
authors ||| S:240 E:247 ||| NNS
'  ||| S:247 E:249 ||| POS
own  ||| S:249 E:253 ||| JJ
studies ||| S:253 E:260 ||| NNS
.  ||| S:260 E:262 ||| .
The  ||| S:262 E:266 ||| DT
importance  ||| S:266 E:277 ||| NN
of  ||| S:277 E:280 ||| IN
these  ||| S:280 E:286 ||| DT
compounds  ||| S:286 E:296 ||| NN
in  ||| S:296 E:299 ||| IN
the  ||| S:299 E:303 ||| DT
regulation  ||| S:303 E:314 ||| NN
of  ||| S:314 E:317 ||| IN
fundamental  ||| S:317 E:329 ||| JJ
biological  ||| S:329 E:340 ||| JJ
processes  ||| S:340 E:350 ||| NNS
has  ||| S:350 E:354 ||| VBZ
been  ||| S:354 E:359 ||| VBN
established  ||| S:359 E:371 ||| VBN
in  ||| S:371 E:374 ||| IN
the  ||| S:374 E:378 ||| DT
last  ||| S:378 E:383 ||| JJ
decades ||| S:383 E:390 ||| NNS
.  ||| S:390 E:392 ||| .
The  ||| S:392 E:396 ||| DT
biochemical  ||| S:396 E:408 ||| JJ
mechanisms  ||| S:408 E:419 ||| NNS
of  ||| S:419 E:422 ||| IN
realization  ||| S:422 E:434 ||| NN
of  ||| S:434 E:437 ||| IN
estrogen  ||| S:437 E:446 ||| JJ
effects  ||| S:446 E:454 ||| NNS
may  ||| S:454 E:458 ||| MD
be  ||| S:458 E:461 ||| VB
considered  ||| S:461 E:472 ||| VBN
as  ||| S:472 E:475 ||| IN
potential  ||| S:475 E:485 ||| JJ
links  ||| S:485 E:491 ||| NNS
of  ||| S:491 E:494 ||| IN
pathogenesis  ||| S:494 E:507 ||| NN
for  ||| S:507 E:511 ||| IN
a  ||| S:511 E:513 ||| DT
number  ||| S:513 E:520 ||| NN
of  ||| S:520 E:523 ||| IN
diseases  ||| S:523 E:532 ||| NNS
and  ||| S:532 E:536 ||| CC
as  ||| S:536 E:539 ||| IN
targets  ||| S:539 E:547 ||| NNS
of  ||| S:547 E:550 ||| IN
their  ||| S:550 E:556 ||| PRP$
therapy ||| S:556 E:563 ||| NN
.  ||| S:563 E:565 ||| .
